ASA: American Society of Anesthesiologists; SD: standard deviation; LUTS: lower urinary tract symptoms; IPSS: International Prostate Symptoms
Score; TRUS: transrectal ultrasound; PSA: prostatic specific antigen; TUIP: transurethral incision of the prostate; QoL: quality of life; Qmax: peak flow rate; PVR: post-void residual urine volume.
In three trials in the United States, Germany, and India on a total of roughly 150 men with BPH, those who took 8 to 30 milligrams of lycopene every day for four months to one year reported no fewer prostate symptoms
than those who took a placebo.
Patients were screened for inclusion in the study if they were 45 years or older and were diagnosed with symptomatic BPH without surgical indication or other acute or emergency BPH treatment, and presented with an I-PSS (International Prostate Symptom
Score) >10 [quality of life (QoL) question of the I-PSS >2].
In an attempt to educate men over 40 of their increased risk of an enlarged prostate and possibly BPH, URINOZINC is sharing its easy to use Prostate Symptoms
The study participants were a subset of the Hypertension and Benign Prostatic Hyperplasia Intervention Trial, an open-label, uncontrolled study of 491 normotensive and hypertensive men with prostate symptoms
who were given doxazosin as initial or add-on therapy.
The primary endpoint was the change in International Prostate Symptom
Score (IPSS) from baseline at Month 24 for combination therapy compared to each medication alone.
In the trial, patients enter a no-treatment run-in observation period to confirm severity and stability of voiding symptoms based on the International Prostate Symptom
In the CombAT study, male patients with moderate-to-severe enlarged prostate symptoms
received placebo for four weeks and then were randomized to receive AVODART and tamsulosin as combination therapy, AVODART as monotherapy, or tamsulosin monotherapy (combination therapy, n=1610; AVODART, n=1623; tamsulosin, n=1611).
The CombAT study includes 4,800 men (combination therapy, n=1492; AVODART, n=1502; tamsulosin, n=1519) with moderate-to-severe enlarged prostate symptoms
Our holmium laser treatments use laser energy to relieve enlarged prostate symptoms
by removing the tissue safely and effectively.
According to the national survey of men age 50 and over, nearly 65 percent of men have not seen a doctor about their prostate symptoms
despite the fact that enlarged prostate, or BPH, is a very common and treatable condition.